Ross Clark is a leader writer and columnist who has written for The Spectator for three decades. His books include Not Zero, The Road to Southend Pier, and Far From EUtopia: Why Europe is failing and Britain could do better
What an enriching business it is, having a global pandemic. That is the conclusion, at any rate, one might reach from reading, in isolation, the government’s figures on employment and earnings. According to the Office of National Statistics (ONS) the average earnings for employees have risen by 4.7 per cent over the past 12 months –
The two vaccines approved and in use in Britain showed high efficacy rates in trials, but it takes time for data to creep through on efficacy in the real-world. We are, however, getting the first figures trickling through. This morning comes a paper evaluating the effectiveness of the Pfizer-BioNTech and AstraZeneca-Oxford vaccines in preventing hospitalisation
Is the British approach of prioritising first doses of Covid vaccines and not promising a second dose until 12 weeks later compromising our ability to fight the disease? It is not a moot point, with several EU figures asserting that it is a risky route to take. As I wrote here a couple of weeks
Last month, Imperial College’s React study claimed that new cases of Covid were static or even rising slightly. This contradicted the figures for confirmed new cases, obtained through the Test and Trace system, which had shown a sharp fall in new cases from the second week of January onwards. Given that React tests a randomised
Before we had vaccines, NHS Test and Trace was supposed to be the breakthrough that would return us to a normal life. After all, testing, tracing and isolating contacts of infected people was credited with keeping Covid infections down in South Korea, Taiwan and elsewhere, so why wouldn’t it work here? Instead, we had a
Bank of England chief economist Andy Haldane last week described the UK economy as a ‘coiled spring’ waiting to rebound just as soon as lockdown restrictions are eased. But is it a spring like the one on which Zebedee from the Magic Roundabout used to bounce around, or is it like a Slinky – the
Will schools in England reopen on 8 March, and if so will it be partially or fully? It is likely to be the first firm measure to be announced when the Prime Minister presents his roadmap back to freedom next Monday. He has, after all, promised to give schools two weeks’ notice of when they will
On Saturday the government hit its target of administering a first vaccine dose to 15 million of the highest-risk groups for Covid 19. By now, everyone over the age of 70, all healthcare workers and vulnerable groups should have been offered a vaccine. It is an impressive achievement which stands in contrast to many of
Well, that’s alright, then — we’re not going to have another recession. True, the Bank of England’s monetary policy committee expects the economy to shrink by 4 per cent in the first quarter of this year — following a fall of 9.9 per cent fall last year, itself the deepest plunge in economic growth in
Not for the first time, metropolitan-based commentators and MPs have proved themselves to be out of kilter with the wider population. But there is an especially interesting disparity over the government’s proposals for ten-year jail sentences for travellers who try to conceal they have travelled from one of 33 ‘red list’ countries in order to
If your local pub ever reopens, don’t be surprised if one thing is missing: the till. The anti-cash lobby is seeking to take advantage of the pandemic to rid us of our banknotes once and for all. When UK Finance — the trade body for the banking and payments industry — pushed the government two
Coronavirus, we have been warned many times, has brought scammers out in force. But lobbyists are not far behind. Their activities may not be illegal, but they are pretty disgraceful nonetheless. Hardly had the coronavirus outbreak begun in January than my email inbox began to fill up with press releases claiming that the contagion was
Reports have filtered through this morning about Public Health England’s assessment of the efficacy of the two vaccines so far administered to the public. The results have not yet been published, but the efficacy rates quoted in the Sun suggest that the Pfizer vaccine has proved to be between 79 and 84 per cent effective at
Scottish Widows is committed to net zero alright. For years, the endowment policy I had with it was worth pretty well just what I had paid into it. Although, on second thoughts, maybe Maria Nazarova-Doyle, head of pension investments at Scottish Widows, wasn’t referring to the returns on its policies when she said this week:
Schools in England, it seems, will reopen fully on 8 March at the earliest – a full two months after they closed. The Prime Minister has declined to bring this forward, in spite of new Covid cases falling at a rate of 25 per cent per week. The Scottish and Welsh governments have both said
What to make of the news this morning that Oxford University is to ask for volunteers to take part in a trial to ‘mix and match’ the Pfizer and AstraZeneca vaccines? Researchers will ask for 820 volunteers, all over 50 years old, who will be given two shots of a vaccine, two weeks apart. Some
Almost a year after the statistics were first published, the country remains horrified by the daily total of Covid 19-related deaths. Meanwhile, we are rather less apt to notice other statistics related to harm and death, which may be an unintended by-product of the fight against Covid-19. The Office of National Statistics’ (ONS) latest figures for the
I’m not a great fan of economic modelling. Remember, for example, the Treasury’s infamous claim that unemployment would rise by between 500,000 and 800,000 within two years of a vote for Brexit (i.e. before we had actually left). In the event, unemployment fell in 2018 to reach the lowest level since the mid-1970s. Yet having
Last year, when Rishi Sunak, after some dithering, came up with a scheme to help the self-employed during the pandemic, he made clear that it would come with a quid pro ro: higher taxes for the self-employed in the longer run. With his second Budget coming up on 3 March will he take the initiative
Ever since the Oxford-AstraZeneca team announced the results of its Phase 3 trials last November, there has been a suspicion among some that their vaccine is the poor relation of the messenger RNA vaccines developed by Pfizer and Moderna. It might be cheap compared with the others, it might be easy to store and transport,
